Peter Scambler

Dr. Peter Scambler

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Cell
Verified
Journal Article
Closed access
AGAaron D. Goldberg
Aaron D. Goldberg
LBLaura A. Banaszynski
Laura A. Banaszynski
KNKyung Min Noh
Kyung Min Noh
PLPeter W. Lewis
Peter W. Lewis
SESimon J. Elsaesser
Simon J. Elsaesser
CAC. David Allis
C. David Allis

19 November 2015 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
DMDonna M McDonald-McGinn
Donna M McDonald-McGinn
KSKathleen E. Sullivan
Kathleen E. Sullivan
BMBruno Marino
Bruno Marino
NPNicole Philip
Nicole Philip
ASAnn Swillen
Ann Swillen
ABAnne S. Bassett
Anne S. Bassett

14 September 2015 in Nature
Verified
Journal Article
Open access
PDF file
TCThe UK10K Consortium
The UK10K Consortium
WGWriting group
Writing group
KWKlaudia Walter
Klaudia Walter
JMJosine L. Min
Josine L. Min
JHJie Huang
Jie Huang
WZWeihua Zhang
Weihua Zhang
The contribution of rare and low-frequency variants to human traits is largely unexplored. Here we describe insights from sequencing whole genomes (low read depth, 7×) or exomes (high read depth, 80×) of nearly 10,000 individuals from population-based and disease collections. In extensively phenotyped cohorts we characterize over 24 million novel sequence variants, generate a highly accurate imputation reference panel and identify novel alleles associated with levels of triglycerides (APOB), adiponectin (ADIPOQ) and low-density lipoprotein cholesterol (LDLR and RGAG1) from single-marker and rare variant aggregation tests. We describe population structure and functional annotation of rare and low-frequency variants, use the data to estimate the benefits of sequencing for association studies, and summarize lessons from disease-specific collections. Finally, we make available an extensive resource, including individual-level genetic and phenotypic data and web-based tools to facilitate the exploration of association results.

1 August 1987 in Nature
Verified
Journal Article
Closed access
PDF file
Walter BodmerWalter Bodmer
Walter Bodmer
CBC. J. Bailey
C. J. Bailey
JBJ. Bodmer
J. Bodmer
HBH. J. R. Bussey
H. J. R. Bussey
AEA. Ellis
A. Ellis
NSN. K. Spurr
N. K. Spurr

1 January 2006 in Developmental Cell
Verified
Journal Article
Closed access
EMEran Meshorer
Eran Meshorer
DYDhananjay Yellajoshula
Dhananjay Yellajoshula
EGEric George
Eric George
PSPeter Scambler
Peter Scambler
DBDavid T. Brown
David T. Brown
TMTom Misteli
Tom Misteli

1 October 1997 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
ARA K Ryan
A K Ryan
JGJ A Goodship
J A Goodship
DWD I Wilson
D I Wilson
NPN Philip
N Philip
ALA Levy
A Levy
PSPeter Scambler
Peter Scambler
We present clinical data on 558 patients with deletions within the DiGeorge syndrome critical region of chromosome 22q11. Twenty-eight percent of the cases where parents had been tested had inherited deletions, with a marked excess of maternally inherited deletions (maternal 61, paternal 18). Eight percent of the patients had died, over half of these within a month of birth and the majority within 6 months. All but one of the deaths were the result of congenital heart disease. Clinically significant immunological problems were very uncommon. Nine percent of patients had cleft palate and 32% had velopharyngeal insufficiency, 60% of patients were hypocalcaemic, 75% of patients had cardiac problems, and 36% of patients who had abdominal ultrasound had a renal abnormality. Sixty-two percent of surviving patients were developmentally normal or had only mild learning problems. The majority of patients were constitutionally small, with 36% of patients below the 3rd centile for either height or weight parameters.